InvestorsHub Logo
icon url

jfr1611

07/08/23 8:12 AM

#607749 RE: hyperopia #607523

“PRICE is what you pay for, VALUE is was you get”
Warren Buffett.

In the case of NWBO, there’s a large gap between them.
icon url

jfr1611

07/08/23 11:30 AM

#607810 RE: hyperopia #607523

Hyperopia,

I think you’re making reference to Kite Pharma who was acquired by Gilead Sciences in 2017 for $11,9B and Juno Therapeutics acquired by Celgene in 2018 for $9B.
But these are CAR-Ts liquid tumours only single target, prior to FDA approval & prior to revenues.

With the MOA demonstrated by Dr Bosch (ASCO early June BNOS & this week in Cambridge UK), how much is the value for NWBO?